|
|
|
|
Vol. 8, Issue 11, 2111-2118, November 1997

§
and
*Department of Cell Biology and Anatomy, Johns Hopkins Medical
School, Baltimore, Maryland 21205; and
Department of
Cell Biology, Albert Einstein College of Medicine, Bronx, New York
10461
| |
ABSTRACT |
|---|
|
|
|---|
Distinct lipid compositions of intracellular organelles could provide a physical basis for targeting of membrane proteins, particularly where transmembrane domains have been shown to play a role. We tested the possibility that cholesterol is required for targeting of membrane proteins to the Golgi complex. We used insect cells for our studies because they are cholesterol auxotrophs and can be depleted of cholesterol by growth in delipidated serum. We found that two well-characterized mammalian Golgi proteins were targeted to the Golgi region of Aedes albopictus cells, both in the presence and absence of cellular cholesterol. Our results imply that a cholesterol gradient through the secretory pathway is not required for membrane protein targeting to the Golgi complex, at least in insect cells.
| |
INTRODUCTION |
|---|
|
|
|---|
The Golgi complex is instrumental in processing and sorting newly
made proteins that move through the secretory pathway in all eukaryotic
cells. Resident proteins that perform Golgi functions have been shown
to contain important targeting information in their transmembrane
domains (Machamer, 1993
; Colley, 1997
), but the mechanism of
localization is still not understood. One hypothesis invokes specific
protein-protein interactions within the lipid bilayer (Nilsson
et al., 1993
). Another is based on differences in lipid
composition, particularly cholesterol and sphingolipids, across the
Golgi stacks (Bretscher and Munro, 1993
).
Sterols are ubiquitous components of cellular membranes in eukaryotes.
In mammalian cells, the major site of cholesterol synthesis is the
endoplasmic reticulum, but the highest concentration is at the plasma
membrane (Liscum and Underwood, 1995
). There is indirect evidence that
an increasing gradient of cholesterol exists through the secretory
pathway (Orci et al., 1981
; Coxey et al., 1993
).
In addition to reducing membrane permeability, an increase in
cholesterol content increases the thickness of model membranes (Levine
and Wilkins, 1971
; Nezil and Bloom, 1992
; Bretscher and Munro, 1993
).
The plasma membrane is therefore expected to be thicker than other
cellular membranes. Bretscher and Munro (1993)
related this observation
to protein sorting by analyzing the potential lengths of Golgi protein
transmembrane domains. They found that, on average, Golgi proteins had
shorter potential transmembrane domains than plasma membrane proteins
with the same topology, and suggested that this might be an important
factor in their sorting. If transport vesicles bud from
cholesterol-rich regions of Golgi membranes, the short transmembrane
domains of Golgi resident proteins may prevent them from entering these
vesicles and leaving the Golgi complex. We tested the hypothesis that
cholesterol provides a physical basis for the localization of Golgi
proteins by examining their distribution in the absence of cholesterol.
Although mammalian cells have been used for most characterizations of
the Golgi complex, they require cholesterol for growth. When deprived
of exogenous cholesterol (normally obtained from lipoproteins in the
form of cholesterol esters), mammalian cells up-regulate the
biosynthesis of cholesterol in the endoplasmic reticulum, and, when
biosynthesis is blocked, they increase endocytosis of lipoproteins to
compensate (Brown and Goldstein, 1986
). Thus, it is very difficult to
manipulate the levels of cholesterol in mammalian cell membranes, and
cellular levels can be depleted to only 30-40% of control levels.
Insect cells are cholesterol auxotrophs, however, and can be depleted
of detectable levels of cholesterol by growth in delipidated serum
without compensatory synthesis of other sterols or major alterations in
the phospholipid profile or fatty acid composition (Silberkang et
al., 1983). We therefore used insect cells to determine whether
cholesterol was required for targeting of Golgi membrane proteins. The
cell line C6/36 derived from Aedes albopictus mosquito
embryos was used because its growth in the absence of cholesterol has
been well characterized (Silberkang et al., 1983; Phalen and
Kielian, 1991
; Marquardt et al., 1993
; Marquardt and
Kielian, 1996
).
| |
MATERIALS AND METHODS |
|---|
|
|
|---|
Cell Culture
C6/36 cells were grown at 28°C in DMEM containing 10%
heat-inactivated fetal bovine serum or 10% delipidated
heat-inactivated fetal bovine serum prepared by adsorption on Cab-O-Sil
as described (Phalen and Kielian, 1991
; Marquardt et al.,
1993
; Marquardt and Kielian, 1996
).
RNA Synthesis and Transfection
cDNA encoding murine
-mannosidase II (GlcNAc transferase
I-dependent
1, 3[
1, 6] mannosidase, Moremen and Robbins, 1991
), originally from K. Moremen was obtained from T. Hobman (University of
Alberta, Edmonton, Alberta, Canada) already subcloned into the pSFV-1
(Life Technologies/BRL, Gaithersburg, MD) expression vector. cDNA
encoding the "short" form of bovine
1,4-galactosyltransferase (UDP-galactose:b-D-N-acetylglucosaminide
1, 4 galactosyltransferase, Russo et al., 1990
) was obtained from
J. Shaper (Johns Hopkins Medical School, Baltimore, MD) and subcloned
into the BamHI site of pSFV-1. cDNAs encoding Iip31 and
1-47GT/Iip31 (Nilsson et al., 1991
) were obtained from T. Nilsson (EMBL, Heidelberg, Germany) and subcloned into pSFV-1 at the
BamHI site. RNA was transcribed from plasmids linearized
with SpeI using SP6 polymerase as recommended by Life
Technologies/BRL with several modifications as described (Rolls
et al., 1994
). Cells were plated on glass coverslips 1-2 d
before transfection and transfected with Semliki Forest virus (SFV) RNA
using Lipofectin (Life Technologies/BRL) as described (Marquardt
et al., 1993
).
Fluorescence Labeling and Microscopy
Cells were labeled with fluorescent probes or conjugated
antibodies and analyzed and photographed using a Nikon (Garden City, NY) Optiphot microscope as described (Machamer et al.,
1993
). For the experiment in Figure 4, a Bio-Rad (Richmond, CA) MRC600 laser scanning confocal microscope was used to view 1-µm optical sections, and images were analyzed and merged using Comos version 6.02 software.
|
Fluorescent Probes
Cells were labeled with 50 µg/ml filipin complex (Sigma, St.
Louis, MO) in PBS for 45 min at room temperature after fixation in 3%
paraformaldehyde (Cadigan et al., 1990
), and photographed using an UV filter. Live cells were stained by incubation in 5 µM
N-[5-(5, 7-dimethyl
BODIPY)-1-pentanoyl]-D-erythro-sphingosine (abbreviated
C5-DMB-cer, Molecular Probes, Eugene, OR) in serum-free medium essentially as described (Pagano et al., 1991
).
Labeling was for 30 min at 2°C, followed by incubation in medium with
normal or delipidated serum for 30 min at 28°C. Cells were fixed,
mounted, and photographed using a rhodamine filter.
Indirect Immunofluorescence
Cells were fixed 16 h posttransfection in 3%
paraformaldehyde and processed for indirect immunofluorescence after
permeabilization with Triton X-100 as described (Machamer et
al., 1993
). Primary antibodies were rabbit anti-rat mannosidase II
(Moremen and Touster, 1985
; Velasco et al., 1993
),
affinity-purified rabbit anti-bovine
1,4-galactosyltransferase
(Shaper et al., 1985
), monoclonal anti-DGC, which recognizes
a carbohydrate epitope in Drosophila Golgi complex membranes
(obtained from V. Malhotra, University of California, San Diego, CA),
and monoclonal antiIip31 [Clonab NL2 (Biotest Diagnostics, Denville,
NJ), received from T. Nilsson (EMBL)]. Secondary antibodies were Texas
red-conjugated goat anti-rabbit immunoglobulin G (IgG) and and goat
anti-mouse IgG, and fluorescein-conjugated goat anti-mouse IgG (Jackson
Immunoresearch, West Grove, PA).
Electron Microscopy
C6/36 cells grown in normal or delipidated serum for nine passages were fixed in 3% glutaraldehyde for 60 min, stained with 1% OsO4 in 0.1 M Na cacodylate, pH 7.2, and embedded in Epon. Thin sections were stained with 2% aqueous uranyl acetate for contrast and photographed at 60 kV using a Zeiss (Thornwood, NY) transmission electron microscope.
| |
RESULTS |
|---|
|
|
|---|
After four or more passages in lipoprotein-deficient serum, C6/36
cells had <2% the level of free and esterified cholesterol as cells
grown in normal serum (Phalen and Kielian, 1991
). Depleted cells failed
to stain with the fluorescent compound filipin, which forms complexes
with cholesterol in membranes (Figure 1).
Even though the cells grown in delipidated serum lacked cholesterol, they had morphologically normal Golgi complexes. Staining cells with
the fluorescent ceramide analog C5-DMB-cer, which labels the Golgi complex in mammalian cells (Pagano et al., 1991
),
revealed a number of punctate structures spread throughout the
cytoplasm in both control and cholesterol-depleted cells (Figure
2, A and B). This dispersed, punctate
labeling pattern is similar to that reported for a Golgi marker in a
Drosophila cell line (Ripoche et al., 1994
). By
electron microscopy, the appearance of Golgi stacks in depleted cells
was indistinguishable from that in control cells (Figure 2, C and D).
At lower magnification (not shown), individual Golgi stacks were seen
throughout the cytoplasm, consistent with the dispersed
C5-DMB-cer staining pattern. Tight clustering of the stacks
in the pericentriolar region was not observed, which suggests that
Golgi complexes in insect cells may not associate with the
microtubule-organizing center, as they do in mammalian cells. The
observation that the morphology of Golgi stacks appears to be unaltered
by cholesterol depletion is consistent with the finding that Golgi
function is not impaired in these cells. There were no differences in
rates of posttranslational processing or in transport to the plasma
membrane for a surface glycoprotein in cholesterol-depleted C6/36 cells
compared with normal cells (Marquardt et al., 1993
).
|
|
Mammalian Golgi proteins might have a more stringent cholesterol
requirement than insect Golgi proteins for correct targeting, since
mammalian cells require cholesterol for growth. We expressed two
well-characterized mammalian Golgi proteins in C6/36 cells by transient
transfection using the SFV expression system (Liljestrom and Garoff,
1991
). SFV replicates in mosquito cells as part of its normal life
cycle, and foreign genes cloned in place of the viral structural
proteins can be expressed when RNA (transcribed in vitro) is
transfected into C6/36 cells. Using this system, we expressed murine
-mannosidase II (ManII) and bovine
1,4-galactosyltransferase (
1, 4GT) in C6/36 cells. Punctate structures throughout the
cytoplasm very similar to those seen in C5-DMB-cer-labeled
cells were observed for both marker proteins in control and
cholesterol-depleted cells (Figure 3).
The punctate staining for ManII and
1,4GT did not colocalize with an
endosomal tracer (fluorescent dextran) or a lysosomal marker
(LysoTracker, Molecular Probes) (our unpublished observations). No
plasma membrane staining was observed for either marker in the
cholesterol-depleted cells, and the staining intensity of the punctate
structures was similar in control and depleted cells. These results
suggested that the two mammalian Golgi proteins were targeted to the
Golgi complex in C6/36 cells, and that depletion of cholesterol had no
effect on the targeting.
|
To confirm that these mammalian proteins were targeted to the insect
Golgi complex, we double-labeled transfected cells with a monoclonal
antibody (anti-DGC) raised to purified Drosophila Golgi
complex membranes. This antibody recognizes a carbohydrate epitope
found on proteins in the Golgi and at lower levels at the plasma
membrane (V. Malhotra, personal communication). Anti-DGC cross-reacts
with mosquito cells and was the only feasible Golgi marker for double
labeling because C5-DMB-cer staining is lost with
permeabilization. Normal and depleted C6/36 cells expressing
1,4GT
are shown in Figure 4. The structures
labeled by anti-DGC (green) were similar to anti
1,4GT-labeled
structures (red), and there was substantial overlap (yellow). In
cholesterol-depleted cells, an increased level of plasma membrane
staining with anti-DGC was observed. However, the intracellular
punctate structures labeled with anti-DGC in cholesterol-depleted cells
still overlapped with expressed
1,4GT (orange and yellow).
Therefore, it is likely that the punctate structures represent Golgi
membranes in both control and cholesterol-depleted cells. Since the
anti-DRG antibody recognizes a carbohydrate epitope on itinerant
proteins rather than a protein epitope on a Golgi membrane protein, the
decreased overlap in staining in the depleted cells does not imply a
loss of retention of endogenous Golgi proteins in these cells. The increased surface staining with anti-DGC in cholesterol-depleted cells
could reflect increased stability of the epitope at the plasma
membrane, decreased synthesis in the Golgi, or both. It will be
interesting to explore the distribution of the DGC epitope in normal
and cholesterol-depleted cells when more is known regarding proteins
that possess this carbohydrate epitope. In C6/36 cells expressing
ManII, the overlap between anti-DGC- and anti-ManII-labeled structures
was less pronounced than that with
1,4GT in both control and
cholesterol-depleted cells (Machamer, unpublished results). This result
suggested that the epitope recognized by anti-DGC is
subcompartmentalized within Golgi membranes, consistent with the
partially overlapping but distinct distributions of ManII and
1,4GT
in mammalian cells (Rabouille et al., 1995
). Unfortunately, the low efficiency of transfection precluded immunoelectron microscopy to localize the transfected markers within the Golgi complex. Thus, we
could not rule out subtle differences in the targeting of the two
marker proteins in the absence of cholesterol. Nevertheless, we could
conclude that cholesterol was not required for targeting of ManII and
1,4GT to the Golgi region of C6/36 cells.
It was possible that the mechanism of protein targeting to Golgi
membranes in insect cells is different than that in mammalian cells. To
determine whether transmembrane domains of Golgi residents were likely
to be involved in targeting, we expressed a chimeric reporter protein.
In mammalian cells, Nilsson et al. (1991)
showed that the
membrane anchor of
1,4GT was sufficient to target the invariant
chain (Iip31) to the Golgi complex. We found this to be the case in
C6/36 cells as well (Figure 5). The amino
terminus (cytoplasmic tail and transmembrane domain) of
1,4GT was
sufficient to target Iip31 (1-47GT/Iip31) to the Golgi region instead
of to endosomes and the plasma membrane, whether or not cholesterol was
present (Figure 5, C and D). Thus, it is likely that Golgi protein
transmembrane domains play an important role in proper targeting in
insect cells, as they do in mammalian cells.
|
| |
DISCUSSION |
|---|
|
|
|---|
Our results imply that a cholesterol gradient through the Golgi
cannot be required for targeting of membrane proteins in insect cells.
Could another factor be responsible for progressively thickening membranes through the secretory pathway in these cells? One possibility might be an increase in the length or unsaturation of fatty acyl chains
of phospholipids. Although we have not investigated this possibility in
C6/36 cells, Silberkang et al. (1983) found that glycerolipid acyl chain length and degree of saturation remained unchanged in Drosophila Kc cells after depletion of
cholesterol. Another possibility is that a gradient of sphingolipids
(which favor thicker bilayers; Bretscher and Munro, 1993
) might be
sufficient for membrane thickening in cholesterol-depleted insect
cells. Sphingolipids in cholesterol-depleted Drosophila or
mosquito cells have not yet been characterized.
One prediction of the Bretscher and Munro hypothesis (Bretscher and
Munro, 1993
) is that altering the length of transmembrane domains could
convert plasma membrane proteins into Golgi residents and vice versa.
Some, but not all, Golgi membrane proteins are retained less
efficiently when their potential transmembrane domains are lengthened
(Munro, 1995
; Colley, 1997
). The plasma membrane protein CD8 was
retained in the Golgi complex when its transmembrane domain was
replaced with 17, but not 23, leucine residues (Munro, 1995
). However,
for another well-characterized plasma membrane protein (the vesicular
stomatitis virus G protein), decreasing the potential transmembrane
length from 20 to 14 amino acids did not prevent its transport to the
cell surface (Adams and Rose, 1985
). It is clear that transmembrane
domain length may play an important role for targeting of some Golgi
proteins, but cell type and protein-specific differences are likely to
exist.
Is membrane thickness involved in protein sorting in the Golgi complex?
Another prediction of the Bretscher and Munro hypothesis (Bretscher and
Munro, 1993
) is that Golgi membrane proteins with short
transmembrane domains would be sequestered away from cholesterol-rich, thicker transport vesicles en route to the plasma membrane. However, a
recent report that COPI- and COPII-coated transport vesicles budding
from Golgi membranes have a thinner interleaflet clear space, compared
with the surrounding membrane, is incompatible with this idea (Orci
et al., 1996
). Finally, there is no direct evidence for a
cholesterol or cholesterol/sphingomyelin gradient through the secretory
pathway. As pointed out by Allan and Kallen (1994)
, the cholesterol in
the trans-Golgi network could be "exogenous" cholesterol
released by hydrolysis of low-density lipoprotein in lysosomes. There
is no evidence that cholesterol synthesized in the endoplasmic
reticulum moves through the Golgi en route to the plasma
membrane, and, in fact, there is evidence that it can bypass the Golgi
(Urbani and Simoni, 1990
). Although the idea that the lipid composition
of Golgi membranes can influence protein localization within the
organelle is an appealing one, more information on the actual lipid
composition of Golgi subcompartment membranes will be required for its
evaluation.
| |
ACKNOWLEDGMENTS |
|---|
We thank J. Shaper, T. Nilsson, T. Hobman, M. Farquhar, K. Moremen, and V. Malhotra for their generous gifts of antibodies and cDNAs, M. Delannoy for expert assistance with confocal microscopy, and M.G. Grim for help with the electron microscopy. This work was supported by the National Institutes of Health (grant GM-42522 to C.E.M.), the American Cancer Society (grant RPG93-013-05VM to M.K.), and the Pew Biomedical Scholars Program (to C.E.M. and M.K.).
| |
FOOTNOTES |
|---|
Present addresses:
Department of Cell Biology,
Harvard Medical School, Boston, MA 02115;
§ Department of
Biology, Stern College, New York, NY 10016.
| |
REFERENCES |
|---|
|
|
|---|
2,6-sialyltransferase specify Golgi retention.
EMBO J.
14, 4695-4704[Medline].
-1,4-galactosyltransferase specifies trans Golgi localization.
EMBO J.
10, 3567-3575[Medline].
1,4-galactosyltransferase: two sets of mRNA transcripts encode two forms of the protein with different amino-terminal domains.
J. Biol. Chem.
265, 3324-3331
-mannosidase I and II.
J. Cell Biol.
122, 39-51This article has been cited by other articles:
![]() |
N. Kucerka, J. D. Perlmutter, J. Pan, S. Tristram-Nagle, J. Katsaras, and J. N. Sachs The Effect of Cholesterol on Short- and Long-Chain Monounsaturated Lipid Bilayers as Determined by Molecular Dynamics Simulations and X-Ray Scattering Biophys. J., September 15, 2008; 95(6): 2792 - 2805. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. Zamir and M. P. Charlton Cholesterol and synaptic transmitter release at crayfish neuromuscular junctions J. Physiol., February 15, 2006; 571(1): 83 - 99. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. M. Rolls, D. H. Hall, M. Victor, E. H. K. Stelzer, and T. A. Rapoport Targeting of Rough Endoplasmic Reticulum Membrane Proteins and Ribosomes in Invertebrate Neurons Mol. Biol. Cell, May 1, 2002; 13(5): 1778 - 1791. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. K. Chatterjee, M. Vashishtha, and M. Kielian Biochemical Consequences of a Mutation That Controls the Cholesterol Dependence of Semliki Forest Virus Fusion J. Virol., February 15, 2000; 74(4): 1623 - 1631. [Abstract] [Full Text] |
||||
![]() |
N. J. Bryant and T. H. Stevens Vacuole Biogenesis in Saccharomyces cerevisiae: Protein Transport Pathways to the Yeast Vacuole Microbiol. Mol. Biol. Rev., March 1, 1998; 62(1): 230 - 247. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||